Association of Inflammation with Depression and Anxiety: Evidence for Symptom-specificity and Potential Causality from UK Biobank and NESDA Cohorts

Overview

Journal Mol Psychiatry

Specialties Molecular Biology
Psychiatry

Date 2021 Jun 17

PMID 34135474

Citations 96

Authors

Yuri Milaneschi

Nils Kappelmann

Zheng Ye

Femke Lamers

Sylvain Moser

Peter B Jones

Stephen Burgess

Brenda W J H Penninx

Golam M Khandaker

Affiliations

Soon will be listed here.

Abstract

We examined whether inflammation is uniformly associated with all depressive and anxiety symptoms, and whether these associations are potentially causal. Data was from 147,478 individuals from the UK Biobank (UKB) and 2,905 from the Netherlands Study of Depression and Anxiety (NESDA). Circulating C-reactive protein (CRP) was measured in both cohorts and interleukin-6 (IL-6) in NESDA. Genetic instruments for these proteins were obtained from published GWAS and UKB. Depressive and anxiety symptoms were assessed with self-report questionnaires. In NESDA, neurovegetative (appetite, sleep, psychomotor) symptoms were disaggregated as increased vs. decreased. In joint analyses, higher CRP was associated with depressive symptoms of depressed mood (OR = 1.06, 95% CI = 1.05-1.08), altered appetite (OR = 1.25, 95%CI = 1.23-1.28), sleep problems (OR = 1.05, 95%CI = 1.04-1.06), and fatigue (OR = 1.12, 95% CI = 1.11-1.14), and with anxiety symptoms of irritability (OR = 1.06, 95% CI = 1.05-1.08) and worrying control (OR = 1.03, 95% CI = 1.02-1.04). In NESDA, higher IL-6 was additionally associated with anhedonia (OR = 1.30, 95% CI = 1.12-1.52). Higher levels of both CRP (OR = 1.27, 95% CI = 1.13-1.43) and IL-6 (OR = 1.26, 95% CI = 1.07-1.49) were associated with increased sleep. Higher CRP was associated with increased appetite (OR = 1.21, 95% CI = 1.08-1.35) while higher IL-6 with decreased appetite (OR = 1.45, 95% CI = 1.18-1.79). In Mendelian Randomisation analyses, genetically predicted higher IL-6 activity was associated with increased risk of fatigue (estimate = 0.25, SE = 0.08) and sleep problems (estimate = 0.19, SE = 0.07). Inflammation was associated with core depressive symptoms of low mood and anhedonia and somatic/neurovegetative symptoms of fatigue, altered sleep and appetite changes. Less consistent associations were found for anxiety. The IL-6/IL-6R pathway could be causally linked to depression. Experimental studies are required to further evaluate causality, mechanisms, and usefulness of immunotherapies for depressive symptoms.

Citing Articles

Associations between IL-6 and trajectories of depressive symptoms across the life course: Evidence from ALSPAC and UK Biobank cohorts.

Edmondson-Stait A, Edmondson-Stait A, Davyson E, Davyson E, Shen X, Shen X Eur Psychiatry. 2025; 68(1):e27.

PMID: 39865800 PMC: 11883784. DOI: 10.1192/j.eurpsy.2025.7.

Trajectory of peripheral inflammation during index ECT in association with clinical outcomes in treatment-resistant depression.

Hough C, Kruse J, Espinoza R, Brooks 3rd J, Congdon E, Norris V Brain Behav Immun Health. 2025; 43():100925.

PMID: 39834556 PMC: 11743860. DOI: 10.1016/j.bbih.2024.100925.

Interleukin-6 in epilepsy and its neuropsychiatric comorbidities: How to bridge the gap.

Chen X, Zhang S, Gao S, Xu M World J Psychiatry. 2025; 15(1):100297.

PMID: 39831011 PMC: 11684222. DOI: 10.5498/wjp.v15.i1.100297.

Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry.

Miller A, Berk M, Bloch G, Briquet-Laugier V, Brouillon C, Cuthbert B Brain Behav Immun. 2025; 125:319-329.

PMID: 39828008 PMC: 11903147. DOI: 10.1016/j.bbi.2025.01.002.

Immuno-metabolic depression: from concept to implementation.

Penninx B, Lamers F, Jansen R, Berk M, Khandaker G, De Picker L Lancet Reg Health Eur. 2025; 48():101166.

PMID: 39801616 PMC: 11721223. DOI: 10.1016/j.lanepe.2024.101166.

References

Udina M, Castellvi P, Moreno-Espana J, Navines R, Valdes M, Forns X . Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J Clin Psychiatry. 2012; 73(8):1128-38. DOI: 10.4088/JCP.12r07694. View

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim E . A meta-analysis of cytokines in major depression. Biol Psychiatry. 2009; 67(5):446-57. DOI: 10.1016/j.biopsych.2009.09.033. View

Howren M, Lamkin D, Suls J . Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009; 71(2):171-86. DOI: 10.1097/PSY.0b013e3181907c1b. View

Haapakoski R, Mathieu J, Ebmeier K, Alenius H, Kivimaki M . Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015; 49:206-15. PMC: 4566946. DOI: 10.1016/j.bbi.2015.06.001. View

Kohler C, Freitas T, Maes M, de Andrade N, Liu C, Fernandes B . Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017; 135(5):373-387. DOI: 10.1111/acps.12698. View

Osimo E, Baxter L, Lewis G, Jones P, Khandaker G . Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med. 2019; 49(12):1958-1970. PMC: 6712955. DOI: 10.1017/S0033291719001454. View

Costello H, Gould R, Abrol E, Howard R . Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open. 2019; 9(7):e027925. PMC: 6661660. DOI: 10.1136/bmjopen-2018-027925. View

Jokela M, Virtanen M, Batty G, Kivimaki M . Inflammation and Specific Symptoms of Depression. JAMA Psychiatry. 2015; 73(1):87-8. DOI: 10.1001/jamapsychiatry.2015.1977. View

Lamers F, Milaneschi Y, de Jonge P, Giltay E, Penninx B . Metabolic and inflammatory markers: associations with individual depressive symptoms. Psychol Med. 2017; 48(7):1102-1110. DOI: 10.1017/S0033291717002483. View

10.

Simmons W, Burrows K, Avery J, Kerr K, Taylor A, Bodurka J . Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states. Mol Psychiatry. 2018; 25(7):1457-1468. PMC: 6292746. DOI: 10.1038/s41380-018-0093-6. View

11.

Moriarity D, Horn S, Kautz M, Haslbeck J, Alloy L . How handling extreme C-reactive protein (CRP) values and regularization influences CRP and depression criteria associations in network analyses. Brain Behav Immun. 2020; 91:393-403. PMC: 7753060. DOI: 10.1016/j.bbi.2020.10.020. View

12.

Kohler-Forsberg O, Buttenschon H, Tansey K, Maier W, Hauser J, Dernovsek M . Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav Immun. 2017; 62:344-350. DOI: 10.1016/j.bbi.2017.02.020. View

13.

Milaneschi Y, Lamers F, Peyrot W, Abdellaoui A, Willemsen G, Hottenga J . Polygenic dissection of major depression clinical heterogeneity. Mol Psychiatry. 2015; 21(4):516-22. PMC: 5546325. DOI: 10.1038/mp.2015.86. View

14.

Milaneschi Y, Lamers F, Peyrot W, Baune B, Breen G, Dehghan A . Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations. JAMA Psychiatry. 2017; 74(12):1214-1225. PMC: 6396812. DOI: 10.1001/jamapsychiatry.2017.3016. View

15.

Lamers F, Milaneschi Y, Vinkers C, Schoevers R, Giltay E, Penninx B . Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study. Brain Behav Immun. 2020; 88:174-183. DOI: 10.1016/j.bbi.2020.04.002. View

16.

Lawlor D, Harbord R, Sterne J, Timpson N, Davey Smith G . Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2007; 27(8):1133-63. DOI: 10.1002/sim.3034. View

17.

Kappelmann N, Arloth J, Georgakis M, Czamara D, Rost N, Ligthart S . Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms: A Genetic Correlation and 2-Sample Mendelian Randomization Study. JAMA Psychiatry. 2020; 78(2):161-170. PMC: 7577200. DOI: 10.1001/jamapsychiatry.2020.3436. View

18.

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J . UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015; 12(3):e1001779. PMC: 4380465. DOI: 10.1371/journal.pmed.1001779. View

19.

Penninx B, Beekman A, Smit J, Zitman F, Nolen W, Spinhoven P . The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res. 2008; 17(3):121-40. PMC: 6878352. DOI: 10.1002/mpr.256. View

20.

Davis K, Coleman J, Adams M, Allen N, Breen G, Cullen B . Mental health in UK Biobank - development, implementation and results from an online questionnaire completed by 157 366 participants: a reanalysis. BJPsych Open. 2020; 6(2):e18. PMC: 7176892. DOI: 10.1192/bjo.2019.100. View